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Osteosarcoma is the most common malignant primary bone tumour 
in children and adolescents, and the second most common primary 
bone tumour overall, after multiple myeloma.1-6 With an estimated 
incidence of approximately 3 - 5 cases/million population per year, 
osteosarcoma has been classified as an orphan disease by the WHO.7
Prior to 1970, the overall survival rate of localised osteosarcoma 
was 10 - 20%.2,8 This survival rate has dramatically improved over 
the last 30 years, to 60 - 70% , as a result of improved chemotherapy 
regimens and surgical techniques.2,4,6,8 To benefit from these advances 
in treatment, the diagnosis must be made prior to progression 
beyond localised disease. Non-metastatic disease is currently curable 
in 60 - 70% of cases.5,6 However, osteosarcoma associated with 
systemic spread carries a much graver prognosis, with cure expected 
in less than 30% of cases.2,6
This study evaluated the clinical stage of osteosarcoma at 
presentation to our tumour unit. Particular emphasis was placed on 
the early signs of disease and radiological findings, to raise awareness 
among doctors who might be the first point of call for these patients 
and their families.
Methods
Between July 2009 and October 2011, 25 patients with suspected 
osteosarcoma were managed at our orthopaedic tumour unit. 
After complete workup and radiological staging, the diagnosis of 
osteosarcoma was confirmed with formal open incisional biopsy. 
Inclusion criteria were patients with histological diagnosis of 
osteosarcoma. Patients were excluded if their records were insufficient 
in terms of the required data. Patients’ charts were reviewed and 
information extracted regarding clinical presentation, histological 
diagnosis and stage of disease.
Results
The records of 25 patients were reviewed; 24 (10 males and 14 
females) met the inclusion and exclusion criteria (Table 1). One 
patient was excluded owing to insufficient data. The median age was 
16 years (range 11 - 53 years).
Patients presented to our unit a median of 4 months after symptom 
onset. The most common presenting complaint was a swelling or 
mass (n=22) followed by pain (n=12) and constitutional symptoms 
(n=2). Pathological fracture at presentation was found in 3 (12.5%) 
patients.
Metaphyseal location around the knee was the most common 
anatomic site, with the distal femur being involved in 13 cases and the 
proximal tibia being involved in 10 (Fig. 1). The remaining case was 
located in the metaphyseal region of the proximal ulna.
Conventional osteosarcoma was the most common histological 
diagnosis and found in 22 out of 24 patients (91.6%); these were 
histologically subdivided into 20 osteoblastic and 2 chondroblastic 
osteosarcomas. The remaining 2 patients had histological diagnoses of 
periosteal osteosarcoma and dedifferentiated parosteal osteosarcoma 
respectively.
At presentation, 16/24 (66.7%) patients had metastatic disease 
(Table 1); metastasis to the lung was the most common site in 12/16 
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Corresponding author: N Ferreira (drferreiran@gmail.com) Fig. 1. Young child with large osteosarcoma involving the distal femur.
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(75%) patients (Fig. 2); 5 had concurrent bony metastases; and 4 had 
bony metastases without radiological evidence of lung metastases.
Eight patients presented without any evidence of metastatic 
disease; 4 of them had advanced local disease, including large tumour 
mass with soft-tissue compromise, neurovascular encasement and 
pathological fracture. Limb salvage was performed in 2/8 patients who 
presented without metastatic disease, both of whom had a proximal 
tibial tumour, and underwent wide resection and megaprosthesis 
total knee replacement.
Three of the patients were older than expected for primary 
osteosarcoma, aged 40, 51 and 53 years, respectively. Two of these 
patients were HIV-1 infected; further research is being conducted 
to determine the causality, if any, between osteosarcoma and HIV-1 
infection.
Discussion
Osteosarcoma is a primary malignant bone tumour that is 
characterised by the proliferation of malignant mesenchymal 
cells capable of the direct production of osteoid.3,4,6,9 The World 
Health Organization’s histological classification further divides 
osteosarcoma into medullary and surface tumours, which are 
each divided into several subtypes. Conventional osteosarcoma 
(the high-grade medullary variant) is the most common subtype, 
making up about 90% of all cases,4,6 and was found in 91.5% of 
our cases.
Patients usually present during the second and third decades of life, 
70 - 75% of patients being between the ages of 15 and 25 years.3,4,6,10 
Our patients had a slightly wider age variance, with 70% being 
between the ages of 11 and 28 years. Lesions are typically located 
in the metaphyseal region of long bones, with the distal femur and 
proximal tibia making up approximately 50% of all cases.3-6,10,11 The 
tumour location in our patients was almost exclusively in the distal 
femur and proximal tibia.
Patients usually present with localised pain and swelling.2,6,10 The 
onset of symptoms is insidious, generally being present for several 
weeks before presentation. Most patients cite incidental trauma as the 
cause of their symptoms. Pain may be activity-related but typically also 
occurs during rest or at night. Constitutional symptoms include weight 
loss, pallor, fever and anorexia.6 At presentation, a limp, loss of function 
or decreased range of motion may be detected.3 The most common 
clinical finding is a mass that is invariably firm and tender. Erythema 
and venous distention are also frequently noted.3 A high index of 
suspicion must be maintained in every child or adolescent who 
complains of pain around the knee, irrespective of a trauma history.
Plain X-rays are indispensable for diagnosis, and the clinical 
suspicion of osteosarcoma is often confirmed by plain radiographs.5 
Typical radiographic findings of an aggressive bone-forming tumour 
with a periosteal reaction and extraskeletal soft tissue extension are 
present in 80 - 90% of cases (Table 2) (Fig. 3).2-4,6,11 Early osteosarcoma, 
however, can often be overlooked or mistaken for benign lesions.12 
Table 1. Patient details
Name Age Gender Site Diagnosis Metastases
G M 14 F Distal femur Conventional osteosarcoma Lung and bony
A D 16 F Distal femur Conventional osteosarcoma Lung
I S 40 F Distal femur Dedifferentiated parosteal osteosarcoma Lung
M M 51 F Distal femur Conventional osteosarcoma Lung and bony
M Z 18 M Proximal tibia Conventional osteosarcoma Lung and bony
S N 18 F Distal femur Conventional osteosarcoma Bony
M N 11 M Distal femur Conventional osteosarcoma None
K N 16 M Proximal tibia Conventional osteosarcoma Lung 
S H 18 M Proximal tibia Conventional osteosarcoma None – unresectable
X N 15 M Proximal tibia Conventional osteosarcoma None – limb salvage
M M 11 F Proximal ulna Conventional osteosarcoma – chondroblastic Bony
M S 20 M Distal femur Conventional osteosarcoma Lung
H J 16 F Proximal tibia Conventional osteosarcoma Lung and bony
L M 11 F Proximal tibia Conventional osteosarcoma Bony
Z N 13 M Proximal tibia Conventional osteosarcoma Bony
M D 14 M Distal femur Conventional osteosarcoma Lung
N D 53 F Proximal tibia Conventional osteosarcoma Lung
S M 21 M Distal femur Conventional osteosarcoma
None – unresectable – large tumour – 
impeding knee ROM
N M 30 F Proximal tibia Conventional osteosarcoma – chondroblastic None – unresectable – 20x20cm mass
T M 17 F Distal femur Conventional osteosarcoma
None – unresectable – pathological 
fracture
B M 20 M Distal femur Conventional osteosarcoma Lung and bony
S Z 16 F Distal femur Conventional osteosarcoma None – AKA performed
Z Z 28 F Proximal tibia Periosteal osteosarcoma None – limb salvage
N K 11 F Distal femur Conventional osteosarcoma Lung
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Therefore, computed tomography (CT) or magnetic resonance 
imaging (MRI) should be used when there is doubt as to the nature 
of a bony lesion in a child or adolescent. These modalities can show 
subtle aggressive features not apparent on plain radiographs.11 Most 
of our patients presented with locally advanced disease and classic 
radiographic findings.
Along with plain radiographs, CT, MRI, bone scintigraphy 
and occasionally angiography are used for diagnosis and staging 
purposes.6 MRI is used to delineate the extent of the tumour, plan 
biopsy and definitive surgery, and identify any possible skip lesions. 
CT scan of the chest and abdomen is performed to identify any 
visceral metastases, while bone scintigraphy should be done to 
rule out bony metastases.6,13 Where available, positron emission 
tomography fluorine-18-fluorodeoxyglucose (PET 18-FDG) may be 
used as an alternative staging modality.13
To confirm the diagnosis of osteosarcoma, a biopsy is always 
required.6 As with all suspected malignant bone tumours, the biopsy 
should be done in a specialised unit by the surgeon who will also 
perform the definitive surgery.5,6,14 Biopsy is preferably done open, 
through a longitudinal incision, without jeopardising possible future 
limb salvage surgery.2 The biopsy incision must be placed in an area 
where it can be totally excised at the time of eventual resection, to 
allow successful limb salvage surgery.5,6,14 All biopsies done at our 
institution are open incisional biopsies, and no postoperative wound 
complications were observed.
Once confirmed histologically, the definitive treatment decision 
is based on the stage of disease and prognosis. Staging is performed 
using the Musculoskeletal Tumour Staging System (Table 3),15,16 
that is based on the histological grade, local extent, and presence 
of metastases. Multiple prognostic factors have been proposed 
including detectable metastases, advanced age, non-extremity 
location, large tumour volume, elevated LDH and ALP, and poor 
histological response to neo-adjuvant chemotherapy.6,8,17 Of these, 
only metastatic disease, tumour size >10 cm, and poor response to 
neo-adjuvant chemotherapy have consistently been associated with 
poor outcome.2,4,6,8,18
The primary surgical objective is complete resection of tumour 
tissue.1 Therefore, limb salvage and prosthetic replacement can only be 
considered if a viable, functional limb remains after resection. If limb 
salvage is considered, pre-operative neo-adjuvant chemotherapeutic 
treatment is instituted to facilitate the surgical dissection. If limb 
salvage is not possible, ablation of the limb may be performed.4 The 
Fig. 2. Chest X-ray showing multiple pulmonary metastases.
Table 2. Radiographic features of tumour
Location Eccentric in metaphysis of long bones
Appearance Mixed areas of lysis and sclerosis
Tumour margin Ill-defined, permeative infiltration into 
normal bone cortex violated without 
expanding bony contour
Tumour matrix Cloud-like appearance with areas of 
calcification
Periosteal reaction Codman’s triangle or sunburst sign
Soft-tissue extension Large circumferential soft-tissue mass
Fig. 3. X-ray showing advanced osteosarcoma of the distal femur.
Table 3. Musculoskeletal Tumour Staging System
Intracompartmental Extracompartmental
Low-grade IA IB
High-grade IIA IIB
Metastatic III III
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literature reports limb salvage rates in excess of 80%,1,6,17 which was 
not possible in our patients as 20/24 (83.3%) patients presented with 
advanced disease precluding limb salvage surgery. Following surgical 
tumour excision, either through limb salvage or ablation, all patients 
are considered for postoperative systemic chemotherapy.
Conclusion
Owing to its relative rarity, osteosarcoma is unfortunately often 
missed on the initial visit to a local hospital. To improve the early 
recognition of osteosarcoma, a high index of suspicion, liberal use 
of radiographs and a sound knowledge of the subtle X-ray changes 
are needed. When faced with a suspected osteosarcoma, consultation 
with a referral unit that specialises in these diseases is advisable, as 
missed or late diagnoses could have catastrophic consequences.
The content of this article is the sole work of the authors. No benefits of 
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